ARUMACIL Trademark

Trademark Overview

On Monday, March 18, 2019, a trademark application was filed for ARUMACIL with the United States Patent and Trademark Office. The USPTO has given the ARUMACIL trademark a serial number of 88345117. The federal status of this trademark filing is SECTION 8 & 15 - ACCEPTED AND ACKNOWLEDGED as of Monday, March 17, 2025. This trademark is owned by Ankh Life Sciences Limited. The ARUMACIL trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the treatment of cold sores
arumacil

General Information

Serial Number88345117
Word MarkARUMACIL
Filing DateMonday, March 18, 2019
Status702 - SECTION 8 & 15 - ACCEPTED AND ACKNOWLEDGED
Status DateMonday, March 17, 2025
Registration Number5905385
Registration DateTuesday, November 5, 2019
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, July 2, 2019

Trademark Statements

Goods and ServicesPharmaceutical preparations for the treatment of cold sores

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateSunday, April 7, 2019
Primary Code005
First Use Anywhere DateThursday, June 20, 2019
First Use In Commerce DateThursday, June 20, 2019

Trademark Owner History

Party NameAnkh Life Sciences Limited
Party Type30 - Original Registrant
Legal Entity Type99 - Other
AddressDublin 2 D02Dk18
IE
Party NameAnkh Life Sciences Limited
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressDublin 2 D02Dk18
IE
Party NameAnkh Life Sciences Limited
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressDublin 2 D02Dk18
IE

Trademark Events

Event DateEvent Description
Thursday, March 21, 2019NEW APPLICATION ENTERED
Sunday, April 7, 2019NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, May 28, 2019ASSIGNED TO EXAMINER
Tuesday, May 28, 2019APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, June 12, 2019NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, July 2, 2019PUBLISHED FOR OPPOSITION
Tuesday, July 2, 2019OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, August 27, 2019NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, September 3, 2019USE AMENDMENT FILED
Tuesday, September 3, 2019TEAS STATEMENT OF USE RECEIVED
Monday, September 23, 2019STATEMENT OF USE PROCESSING COMPLETE
Monday, September 23, 2019CASE ASSIGNED TO INTENT TO USE PARALEGAL
Monday, September 30, 2019ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Tuesday, November 19, 2024TEAS SECTION 8 & 15 RECEIVED
Tuesday, October 1, 2019NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Tuesday, November 5, 2019REGISTERED-PRINCIPAL REGISTER
Tuesday, November 5, 2024COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Monday, March 17, 2025CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Monday, March 17, 2025REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
Monday, March 17, 2025NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
Wednesday, April 2, 2025ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Wednesday, April 2, 2025TEAS CHANGE OF CORRESPONDENCE RECEIVED
Wednesday, April 2, 2025TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Wednesday, April 2, 2025TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS

Related Keywords

arumacil sores cold treatment preparations pharmaceutical